SIOX — Sio Gene Therapies Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapMomentum Trap

Annual balance sheet for Sio Gene Therapies, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2018 March 31st	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	154	107	80.8	119	63.7
Net Total Receivables	1.75	1.73	1.71	6	1.61
Prepaid Expenses
Total Other Current Assets
Total Current Assets	158	115	85.4	132	71.7
Net Property, Plant And Equipment	2.52	1.28	2.33	1.63	3.34
Long Term Investments
Other Long Term Assets
Total Assets	161	123	93.7	135	75.1
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	46.6	43.5	32	10.8	13
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	89.5	66.5	32.1	11.8	14.7
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	71.3	56.2	61.6	123	60.3
Total Liabilities & Shareholders' Equity	161	123	93.7	135	75.1
Total Common Shares Outstanding